CoreCap Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
ATO
CoreCap Advisors's MRK Position: Q2 2026 in Review
CoreCap Advisors increased its Merck (MRK) stake by 6.3% in Q2 2026, buying an estimated $427K and bringing the position to 61,485 shares worth $7.9M. The position accounts for 0.23% of the portfolio, ranked #88.
CoreCap Advisors first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- CoreCap Advisors held 61,485 shares of Merck worth $7.9M as of Q2 2026.
- CoreCap Advisors bought 3,645 Merck shares in Q2 2026, an estimated $427K.
- Merck made up 0.23% of CoreCap Advisors's portfolio in Q2 2026, its #88 holding.
- CoreCap Advisors first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
- 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.